You are here

Pharmaceuticals and Healthcare

The business of vital innovation


The pharmaceutical and healthcare sector is one of the world’s most vital and innovative.

Against a backdrop of technological change and an increasing and aging population, we partner with our clients to help them achieve their goals, capitalise on opportunities and navigate uncertainty.

Combining deep scientific, technical and strategic knowledge we help our clients by providing the commercial nous, experience and range of services that only a large international professional services firm can offer, to anticipate and deliver innovative and value-enhancing solutions.

Recent Experience


Advising AbbVie on its proposed US$55 billion takeover of Shire, a FTSE-100 pharmaceutical company

Claris Life Sciences Limited

Acting for Claris Life Sciences Limited on the sale of its Global Generic Injectables Business to Baxter for US$ 625 million


Representing Gilead in the successful defence of claims for patent infringement in both the UK and Australia brought by Idenix. These claims related to Gilead’s cure for Hepatitis C, sofosbuvir, worth over $10 billion in worldwide annual sales


Representing Ariosa, a subsidiary of Roche, in patent infringement proceedings brought against it in both the English High Court and the Australian Federal Court in relation to its Harmony® non-invasive prenatal test


Advising Diageo in relation to product liability issues arising from the distribution of Thalidomide in the late 1950s/early 1960s.

BioPharma Credit PLC

Advising BioPharma Credit PLC, a new listed investment fund managed by Pharmakon Advisors LP and investing in the life sciences industry, on its proposed IPO and listing on the London Stock Exchange

Insights and updates

6th October 2022
In the area of patent law, clarity is king. Where precision of language is essential...
19th August 2022
On 18 August 2022, the Commonwealth Government released draft legislation proposing five-fold increases in the...
25th March 2022
Last week, a Full Court of the Federal Court of Australia handed down two unanimous...
18th November 2021
‘Cyber-ransoms’ are on the rise, and with new cyber tactics and ways of working, the...

Related news and deals

05 May 2023

Kewei promotes capital markets international partner in China joint operation with Herbert Smith Freehills 科伟史密夫斐尔联营办公室晋升资本市场业务资深国际顾问

15 December 2022

Herbert Smith Freehills advises joint sponsors on 3D Medicines' Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为思路迪香港上市提供法律服务